You are here

Article Text

Article menu
Letters to the editor
Cenesthetic hallucinations in a patient with Parkinson’s disease
  1. FÉLIX JAVIER JIMÉNEZ-JIMÉNEZ,
  2. MIGUEL ORTÍ-PAREJA,
  3. TERESA GASALLA,
  4. ANTONIO TALLÓN-BARRANCO,
  5. FRANCISCO CABRERA-VALDIVIA
  1. Department of Neurology
  2. Department of Psychiatry, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, Spain
  1. Dr Félix Javier Jiménez Jiménez, C/Corregidor José de Pasamonte, 24, 3º D, E-28030 Madrid, Spain.
  1. ALBERTO FERNÁNDEZ-LLIRIA
  1. Department of Neurology
  2. Department of Psychiatry, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, Spain
  1. Dr Félix Javier Jiménez Jiménez, C/Corregidor José de Pasamonte, 24, 3º D, E-28030 Madrid, Spain.

https://doi.org/10.1136/jnnp.63.1.120

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Hallucinations are a side effect of treatment with levodopa and dopamine agonists. They are more common in patients with Parkinson’s disease with advanced age and cognitive impairment.1-3Hallucinations secondary to dopaminergic drugs are usually visual, and less often, auditory.4 We describe a patient who developed cenesthetic hallucinations during pergolide and levodopa treatment.

    A 66 year old woman with Parkinson’s disease, predominantly rigid akinetic, had been treated with carbidopa-levodopa since the age of 55 in 1984. When she was evaluated for the first time in our …

    View Full Text